Continuous Infusions vs Scheduled Bolus Infusions

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT03230565
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Pain, Postoperative
  • Surgical Procedure, Unspecified

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ropivacaine — DRUG
    Patient will be given a continuous infusion of local anesthetic.
  • Ropivacaine — DRUG
    Patient will be given a scheduled intermittent bolus of local anesthetic.

Study Details

The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.

Key Dates

Start date
Jun 1, 2018
Status verified
Nov 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
240 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Continuous Infusion
    Local anesthetic medication (Ropivacaine 0.2%) is provided at a continuous basal rate.
  • Active Comparator: Intermittent Bolus Infusion
    Local anesthetic medication (Ropivacaine 0.2%) is provided in scheduled, intermittent boluses.

Primary Outcome Measure

Post-surgical pain [ Time Frame: Post-operative day 0, 1, and 2 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Archana Verma
Jean Louis-Horn, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Stanford, CA

By research site
Stanford University· Stanford, CA

Related Studies